CBT · Cabot Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $904.00M | $849.00M | $923.00M | $936.00M | $955.00M | $1.02B | $1.02B | $958.00M | $968.00M | $1.03B |
| Cost of Revenue | $694.00M | $638.00M | $679.00M | $695.00M | $720.00M | $760.00M | $773.00M | $740.00M | $745.00M | $823.00M |
| Gross Profit | $210.00M | $211.00M | $244.00M | $241.00M | $235.00M | $256.00M | $246.00M | $218.00M | $223.00M | $210.00M |
| R&D | $14.00M | $13.00M | $15.00M | $15.00M | $14.00M | $16.00M | $15.00M | $15.00M | $15.00M | $15.00M |
| SG&A | $67.00M | $69.00M | $62.00M | $64.00M | $66.00M | $68.00M | $75.00M | $67.00M | $58.00M | $66.00M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | $41.00M | - | - | $37.00M | - | - | $41.00M | - | - |
| Operating Income | $129.00M | $129.00M | $167.00M | $162.00M | $155.00M | $172.00M | $156.00M | $136.00M | $150.00M | $129.00M |
| Interest Expense | $18.00M | $18.00M | $19.00M | $19.00M | $18.00M | $19.00M | $21.00M | $22.00M | $24.00M | $23.00M |
| Income Tax | $44.00M | $37.00M | $43.00M | $49.00M | $41.00M | $40.00M | $47.00M | $34.00M | $41.00M | $29.00M |
| Net Income | $68.00M | $73.00M | $101.00M | $94.00M | $93.00M | $109.00M | $84.00M | $50.00M | $82.00M | $75.00M |
| EPS - Basic | $1.27 | $1.38 | $1.87 | $1.71 | $1.69 | $1.96 | $1.50 | $0.88 | $1.44 | $1.31 |
| EPS - Diluted | $1.27 | $1.37 | $1.86 | $1.69 | $1.67 | $1.94 | $1.49 | $0.88 | $1.43 | $1.29 |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $252.00M | $230.00M | $258.00M | $213.00M | $183.00M | $223.00M | $206.00M | $244.00M | $238.00M | $205.00M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $522.00M | $503.00M | $504.00M | $541.00M | $536.00M | $552.00M | $551.00M | $617.00M | $585.00M | $625.00M |
| Accounts Payable | - | - | $459.00M | - | - | $495.00M | - | - | $438.00M | - |
| Current Assets | $1.55B | $1.46B | $1.54B | $1.60B | $1.50B | $1.60B | $1.60B | $1.69B | $1.63B | $1.74B |
| Total Assets | $3.90B | $3.76B | $3.81B | $3.78B | $3.64B | $3.74B | $3.60B | $3.69B | $3.60B | $3.52B |
| Current Liabilities | $1.07B | $874.00M | $957.00M | $818.00M | $747.00M | $772.00M | $718.00M | $830.00M | $822.00M | $904.00M |
| Long-term Debt | $863.00M | $854.00M | $856.00M | $1.09B | $1.09B | $1.09B | $1.09B | $1.10B | $1.09B | $1.09B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $1.57B | $1.57B | $1.55B | $1.43B | $1.37B | $1.43B | $1.37B | $1.33B | $1.26B | $1.10B |
| Retained Earnings | $1.83B | $1.84B | $1.83B | $1.80B | $1.77B | $1.73B | $1.63B | $1.58B | $1.57B | $1.36B |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | $126.00M | - | - | $124.00M | - | - | $105.00M | - | - |
| Investing Cash Flow | - | ($69.00M) | - | - | ($104.00M) | - | - | ($54.00M) | - | - |
| Financing Cash Flow | - | ($92.00M) | - | - | ($24.00M) | - | - | ($29.00M) | - | - |
| CapEx | - | $69.00M | - | - | $77.00M | - | - | $54.00M | - | - |
| Free Cash Flow | - | $57.00M | - | - | $47.00M | - | - | $51.00M | - | - |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 23.2% | 24.9% | 26.4% | 25.7% | 24.6% | 25.2% | 24.1% | 22.8% | 23.0% | 20.3% |
| Operating margin | 14.3% | 15.2% | 18.1% | 17.3% | 16.2% | 16.9% | 15.3% | 14.2% | 15.5% | 12.5% |
| EBITDA margin | - | 20.0% | - | - | 20.1% | - | - | 18.5% | - | - |
| Net margin | 7.5% | 8.6% | 10.9% | 10.0% | 9.7% | 10.7% | 8.2% | 5.2% | 8.5% | 7.3% |
| Free cash flow margin | - | 6.7% | - | - | 4.9% | - | - | 5.3% | - | - |
| FCF / Net income | - | 0.78 | - | - | 0.51 | - | - | 1.02 | - | - |
| R&D / Revenue | 1.5% | 1.5% | 1.6% | 1.6% | 1.5% | 1.6% | 1.5% | 1.6% | 1.5% | 1.5% |
| SG&A / Revenue | 7.4% | 8.1% | 6.7% | 6.8% | 6.9% | 6.7% | 7.4% | 7.0% | 6.0% | 6.4% |
| Effective tax rate | 39.3% | 33.6% | 29.9% | 34.3% | 30.6% | 26.8% | 35.9% | 40.5% | 33.3% | 27.9% |
| Return on assets | 1.7% | 1.9% | 2.6% | 2.5% | 2.6% | 2.9% | 2.3% | 1.4% | 2.3% | 2.1% |
| Return on equity | 4.3% | 4.6% | 6.5% | 6.6% | 6.8% | 7.6% | 6.1% | 3.8% | 6.5% | 6.8% |
| Return on invested capital | 3.2% | 3.5% | 4.9% | 4.2% | 4.4% | 5.0% | 4.1% | 3.3% | 4.2% | 4.2% |
| Liquidity | ||||||||||
| Current ratio | 1.45 | 1.67 | 1.61 | 1.96 | 2.00 | 2.08 | 2.24 | 2.04 | 1.98 | 1.93 |
| Quick ratio | 0.96 | 1.09 | 1.08 | 1.30 | 1.29 | 1.36 | 1.47 | 1.30 | 1.27 | 1.24 |
| Cash ratio | 0.24 | 0.26 | 0.27 | 0.26 | 0.24 | 0.29 | 0.29 | 0.29 | 0.29 | 0.23 |
| Leverage | ||||||||||
| Debt / Equity | 0.55 | 0.54 | 0.55 | 0.76 | 0.80 | 0.76 | 0.80 | 0.83 | 0.87 | 1.00 |
| Debt / Assets | 0.22 | 0.23 | 0.22 | 0.29 | 0.30 | 0.29 | 0.30 | 0.30 | 0.30 | 0.31 |
| Debt / EBITDA | - | 5.02 | - | - | 5.67 | - | - | 6.20 | - | - |
| Interest coverage | 7.2x | 7.2x | 8.8x | 8.5x | 8.6x | 9.1x | 7.4x | 6.2x | 6.3x | 5.6x |
| Equity multiplier | 2.49 | 2.39 | 2.46 | 2.65 | 2.67 | 2.62 | 2.63 | 2.78 | 2.85 | 3.20 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.23 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.26 | 0.27 | 0.29 |
| Inventory turnover | 1.33 | 1.27 | 1.35 | 1.28 | 1.34 | 1.38 | 1.40 | 1.20 | 1.27 | 1.32 |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 275d | 288d | 271d | 284d | 272d | 265d | 260d | 304d | 287d | 277d |
| Days payable outstanding | - | - | 247d | - | - | 238d | - | - | 215d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 59.3x | 48.4x | 40.9x | 49.2x | 54.7x | 57.6x | 61.9x | 94.9x | 48.4x | 59.4x |
| P / B | 2.5x | 2.2x | 2.6x | 3.2x | 3.7x | 4.4x | 3.8x | 3.5x | 3.1x | 4.0x |
| P / S | 4.3x | 4.1x | 4.4x | 4.8x | 5.3x | 6.1x | 5.0x | 4.9x | 4.0x | 4.2x |
| EV / EBITDA | - | 24.3x | - | - | 30.9x | - | - | 31.1x | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -3.4% | -11.1% | -9.2% | -8.1% | -0.3% | 5.0% | -1.4% | -0.7% | -15.8% | -5.4% |
| Revenue CAGR (3y) | -4.3% | -4.2% | -7.0% | -5.0% | -0.4% | 3.5% | 6.6% | 8.7% | 23.2% | 13.3% |
| Revenue CAGR (5y) | 1.4% | 2.6% | 12.2% | 5.7% | 5.6% | 3.8% | 3.8% | 3.1% | 2.5% | 4.8% |
| Gross profit growth (YoY) | -12.9% | -10.2% | -4.7% | -2.0% | 7.8% | 14.8% | 17.1% | 20.4% | -5.1% | -9.5% |
| Operating income growth (YoY) | -20.4% | -16.8% | -2.9% | 3.8% | 14.0% | 14.7% | 20.9% | 29.5% | -10.7% | -19.9% |
| Net income growth (YoY) | -27.7% | -21.5% | -7.3% | 11.9% | 86.0% | 32.9% | 12.0% | -7.4% | -15.5% | -29.9% |
| EPS growth (YoY) | -24.9% | -18.0% | -4.1% | 13.4% | 89.8% | 35.7% | 15.5% | -5.4% | -15.4% | -29.9% |
| EPS CAGR (3y) | -0.5% | 13.8% | 3.2% | -2.8% | - | 9.4% | 4.7% | -6.0% | - | - |
| EPS CAGR (5y) | -0.5% | 5.3% | - | - | 19.0% | 28.7% | 30.7% | -5.0% | 0.4% | - |
| FCF growth (YoY) | - | 21.3% | - | - | -7.8% | - | - | 200.0% | - | - |
| FCF CAGR (5y) | - | - | - | - | 4.9% | - | - | - | - | - |
| Book value growth (YoY) | 9.9% | 15.3% | 8.8% | 4.4% | 2.8% | 12.7% | 24.4% | 31.7% | 40.8% | 19.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-09-30.
Business segments
$3.59B totalReinforcement Materials$2.34B · 65.2%
Performance Chemicals$1.25B · 34.8%
Product / service
$122.00M totalShipping And Handling$112.00M · 91.8%
Other Products And Services$10.00M · 8.2%
Geographic
$6.05B totalOther Foreign Countries$2.11B · 34.9%
Americas$944.00M · 15.6%
CN$931.00M · 15.4%
Asia Pacific$865.00M · 14.3%
US$670.00M · 11.1%
EMEA$532.00M · 8.8%
Peer comparison
Same SIC group: Miscellaneous Chemical Products
Comparing CABOT CORP against the 5 most active filers in the same SIC group.
Dividends
$1.82/share trailing 12 months · +4.8% YoY
| Ex-date | Per share |
|---|---|
| May 29, 2026 | $0.4730 |
| Feb 27, 2026 | $0.4500 |
| Nov 28, 2025 | $0.4500 |
| Aug 29, 2025 | $0.4500 |
| May 30, 2025 | $0.4500 |
| Feb 28, 2025 | $0.4300 |
| Nov 29, 2024 | $0.4300 |
| Aug 30, 2024 | $0.4300 |
| May 31, 2024 | $0.4300 |
| Feb 22, 2024 | $0.4000 |
| Nov 22, 2023 | $0.4000 |
| Aug 24, 2023 | $0.4000 |
| May 25, 2023 | $0.4000 |
| Feb 23, 2023 | $0.3700 |
| Nov 23, 2022 | $0.3700 |
| Aug 25, 2022 | $0.3700 |
| May 26, 2022 | $0.3700 |
| Feb 24, 2022 | $0.3700 |
| Nov 24, 2021 | $0.3700 |
| Aug 26, 2021 | $0.3500 |
| May 27, 2021 | $0.3500 |
| Feb 25, 2021 | $0.3500 |
| Nov 25, 2020 | $0.3500 |
| Aug 27, 2020 | $0.3500 |